Based on those results, we then evaluated serum levels of CCL22, CXCL5, and CXCL10 in 25 patients with CTCL, revealing that CCL22 was significantly increased in advanced CTCL compared with early CTCL. The gene discussed is CXCL10; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.